Cardinal Health, a global leader in healthcare services and pharmaceutical distribution, has announced a significant expansion of its home-based healthcare portfolio through the simultaneous acquisition of Strive Medical and the diabetes business unit of AdaptHealth. The dual-transaction deal, valued at approximately $360 million, represents a major milestone in the company’s ongoing strategy to capitalize on the rapidly growing "hospital-at-home" market. By integrating these specialized entities, Cardinal Health aims to solidify its position as a primary provider of medical supplies and management services for chronic conditions, specifically focusing on the high-demand areas of urology and diabetes care.
The acquisitions are designed to bolster Cardinal Health’s At-Home Solutions business, a segment that has seen aggressive investment over the past year. As the healthcare landscape shifts away from traditional clinical settings toward more cost-effective and patient-centric home environments, Cardinal Health is positioning itself to manage the complex logistics and clinical support required for home-based chronic disease management. The $360 million investment underscores the company’s commitment to building a comprehensive infrastructure capable of serving millions of patients who require daily medical supplies to manage their health outside of the hospital.
Strategic Integration and Market Expansion
The acquisition of Strive Medical, a provider of urological and wound care supplies, serves as a direct extension of Cardinal Health’s recent efforts to dominate the urology supply chain. Simultaneously, the purchase of AdaptHealth’s diabetes unit complements Cardinal’s existing diabetes infrastructure, which was significantly enhanced earlier in 2025. These moves are not merely about increasing market share; they are about creating a vertically integrated service model where Cardinal Health controls the distribution, the patient relationship, and the digital referral pathways.
In the diabetes sector, the integration of AdaptHealth’s assets follows the successful acquisition of Advanced Diabetes Supply (ADS) in April 2025. By folding these new assets into the ADS framework, Cardinal Health is creating a powerhouse in diabetes management, a field that is currently witnessing a technological revolution with the widespread adoption of Continuous Glucose Monitors (CGMs) and automated insulin delivery systems. The inclusion of AdaptHealth’s diabetes customer base allows Cardinal to scale its operations rapidly, leveraging its existing distribution network to improve delivery speeds and reduce operational overhead.
On the urology front, the acquisition of Strive Medical provides Cardinal Health with a sophisticated platform for managing specialized urological needs. This follows a flurry of activity in mid-2025, including the $1.9 billion acquisition of Solaris Health. By combining Strive’s specialized focus with Solaris’s broad reach, Cardinal Health is building a comprehensive urological ecosystem that caters to both independent urology practices and individual patients managing conditions such as chronic kidney disease or urinary incontinence at home.
A Chronology of Aggressive Growth
To understand the significance of these latest acquisitions, it is essential to view them within the context of Cardinal Health’s broader M&A timeline over the past 18 months. The company has moved with remarkable speed to transition from a traditional wholesaler into a diversified healthcare services provider.
- April 2025: Cardinal Health executes a multi-pronged entry into specialized home care by acquiring Advanced Diabetes Supply (ADS), Urology America, and Potomac Urology. These deals established the initial footprint for the company’s specialized "at-home solutions" strategy.
- August 2025: The company makes its largest recent play with the $1.9 billion acquisition of Solaris Health, a leading provider of urological services. This was followed immediately by the acquisition of Academic Urology & Urogynecology, signaling a clear intent to own the urology market end-to-end.
- Late 2025 – Early 2026: Cardinal Health focuses on internal integration, migrating ADS volumes onto its primary distribution network and launching the ContinuCare Pathway, a digital tool designed to simplify the transition from hospital discharge to home-based supply delivery.
- Present Day: The $360 million acquisition of Strive Medical and AdaptHealth’s diabetes unit serves as a "bolt-on" strategy to fill remaining gaps in geographic coverage and service depth, bringing the total number of new customers onboarded in the last fiscal year to nearly 500,000.
Operational Synergies and Digital Innovation
A critical component of Cardinal Health’s strategy is the "ContinuCare Pathway," a pharmacy-to-supplier digital referral programme. This platform addresses one of the most significant pain points in home healthcare: the gap between a doctor’s prescription and the patient receiving the necessary supplies at home. By integrating Strive Medical and the AdaptHealth unit into this digital ecosystem, Cardinal Health can automate much of the administrative burden associated with insurance verification and supply replenishment.
Rob Schlissberg, President of Cardinal Health At-Home Solutions, highlighted that the company’s operational achievements in the 2026 fiscal year have laid the groundwork for this expansion. According to Schlissberg, the ability to migrate high volumes of specialized medical supplies onto a single, unified distribution network is what differentiates Cardinal from its competitors. This migration allows for better inventory management, reduced shipping costs, and a more consistent experience for the patient.
The company has already demonstrated the success of this model with the integration of ADS. Since that acquisition, Cardinal has successfully onboarded half a million new customers without significant service disruptions. The current $360 million investment is expected to follow a similar integration roadmap, with the goal of achieving full operational synergy within the next twelve to eighteen months.
Leadership Vision and Industry Implications
Cardinal Health CEO Jason Hollar has been vocal about the "natural extension" of the company’s growth strategy. In statements regarding the latest deals, Hollar emphasized that these transactions build on the synergies created by previous investments. The objective is to provide "high-quality service at scale," a necessity in a healthcare market where the volume of home-based patients is skyrocketing.
The broader implications for the healthcare industry are profound. Cardinal Health’s pivot toward specialized home care reflects a wider trend among major distributors, such as McKesson and Cencora (formerly AmerisourceBergen), who are also seeking higher-margin service opportunities beyond simple drug wholesaling. By focusing on diabetes and urology—two therapeutic categories characterized by high patient volumes and recurring supply needs—Cardinal Health is securing a steady, long-term revenue stream that is less susceptible to the pricing pressures seen in the generic pharmaceutical market.
Furthermore, the "hospital-at-home" movement is gaining traction with payers, including Medicare and private insurers, who see home care as a way to reduce the $4.5 trillion annually spent on healthcare in the United States. Cardinal Health’s ability to provide the "pipes and wires" for this movement—the catheters, glucose sensors, and wound dressings—makes them an indispensable partner for insurance companies and health systems looking to transition patients out of expensive hospital beds.
Supporting Data and Demographic Drivers
The financial logic behind the $360 million deal is supported by clear demographic trends. The United States is facing an aging population crisis, with roughly 10,000 "Baby Boomers" turning 65 every day. This demographic shift is directly linked to an increase in chronic conditions.
In the diabetes sector, data from the Centers for Disease Control and Prevention (CDC) indicates that over 38 million Americans have diabetes, with another 97 million adults having prediabetes. The market for diabetes management devices and supplies is projected to grow at a compound annual growth rate (CAGR) of over 6% through 2030. By acquiring AdaptHealth’s unit, Cardinal Health is positioning itself to capture a larger slice of this expanding pie.
Similarly, the urology market is driven by an aging population and a rising prevalence of urinary tract infections, kidney stones, and prostate issues. The global urological supplies market is expected to reach significant billions by the end of the decade. Cardinal’s strategy of acquiring localized and specialized providers like Strive Medical allows them to provide a level of clinical expertise that a general distributor cannot match.
Future Outlook and Market Reaction
Market analysts have generally viewed Cardinal Health’s aggressive M&A strategy as a positive move toward diversification. By spending $360 million on these two units, the company is demonstrating a disciplined approach to capital allocation—choosing targeted, high-value assets that can be easily integrated into their existing "At-Home Solutions" infrastructure.
Looking ahead, the industry can expect Cardinal Health to continue its search for acquisition targets in other chronic care categories. Respiratory health, home infusion therapy, and advanced wound care are all logical next steps for a company that is rapidly becoming the dominant force in home-based medical supply chains.
The success of these acquisitions will ultimately be measured by the company’s ability to maintain high service levels while managing a massive increase in patient volume. If the integration of Strive Medical and the AdaptHealth diabetes unit follows the successful trajectory of the ADS acquisition, Cardinal Health will have effectively built a "moat" around its home care business, making it difficult for smaller competitors to challenge its scale and technological advantages.
In a highly dynamic and increasingly digital industry, Cardinal Health’s latest move signals a clear transition from a logistical middleman to a vital clinical partner in the home healthcare ecosystem. As more care moves into the living room, Cardinal Health is ensuring it has the supplies, the technology, and the scale to meet the patient where they are.
